RNS Number : 6388A
Tiziana Life Sciences PLC
23 January 2020
Tiziana Life Sciences plc
("Tiziana" or the "Company")
Tiziana Life Sciences Announces F-3 Filing
New York/London, 23 January 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces the Company has today filed a Form F-3 with the Securities Exchange Commission. An F-3 filing is a shelf registration statement for securities which may enable the Company to potentially conduct a future fundraising (but absent any specific terms at the current time).
Contacts:
|
Tiziana Life Sciences plc
Gabriele Cerrone, Chairman and founder
|
+44 (0)20 7495 2379
|
|
|
|
|
Cairn Financial Advisers LLP (Nominated adviser)
Liam Murray / Jo Turner
|
+ 44 (0)20 7213 0880
|
|
|
|
|
Shore Capital (Broker)
Antonio Bossi / Fiona Conroy
|
+44 (0)20 7601 6125
|
Receive news and updates from Tiziana Life Sciences plc by signing up to get email alerts straight to you on https://ir.tizianalifesciences
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the
Financial Conduct Authority to act as a Primary Information Provider in the
United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com or visit
www.rns.com.
END
MSCKKBBDABKDADB
